153 related articles for article (PubMed ID: 28428051)
1. Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury.
Griffin JI; Cheng SKK; Hayashi T; Carson D; Saraswathy M; Nair DP; Simberg D
Nanomedicine; 2017 Aug; 13(6):1925-1932. PubMed ID: 28428051
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
[TBL] [Abstract][Full Text] [Related]
3. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
4. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.
Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J
Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848
[TBL] [Abstract][Full Text] [Related]
5. Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats.
Strittmatter F; Gandaglia G; Benigni F; Bettiga A; Rigatti P; Montorsi F; Gratzke C; Stief C; Colciago G; Hedlund P
Eur Urol; 2012 Jan; 61(1):98-106. PubMed ID: 21930339
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravesical capsaicin and vehicle on bladder integrity control and spinal cord injured rats.
Byrne DS; Das A; Sedor J; Huang B; Rivas DA; Flood HJ; DeGroat W; Jordan ML; Chancellor MB; McCue P
J Urol; 1998 Mar; 159(3):1074-8. PubMed ID: 9474234
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer.
Martin DT; Hoimes CJ; Kaimakliotis HZ; Cheng CJ; Zhang K; Liu J; Wheeler MA; Kelly WK; Tew GN; Saltzman WM; Weiss RM
Nanomedicine; 2013 Nov; 9(8):1124-34. PubMed ID: 23764660
[TBL] [Abstract][Full Text] [Related]
8. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery.
GuhaSarkar S; More P; Banerjee R
J Control Release; 2017 Jan; 245():147-156. PubMed ID: 27913307
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
Li G; Lei Q; Wang F; Deng D; Wang S; Tian L; Shen W; Cheng Y; Liu Z; Wu S
Small; 2019 Jun; 15(25):e1900936. PubMed ID: 31074941
[TBL] [Abstract][Full Text] [Related]
10. Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid.
Baig M; Miocinovic R; Keck RW; Fynes EM; Strobel SL; Kropp KA; Selman SH
J Urol; 2007 Sep; 178(3 Pt 1):1108-12. PubMed ID: 17644132
[TBL] [Abstract][Full Text] [Related]
11. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.
Hauser PJ; Buethe DA; Califano J; Sofinowski TM; Culkin DJ; Hurst RE
J Urol; 2009 Nov; 182(5):2477-82. PubMed ID: 19765766
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy.
Lu S; Neoh KG; Kang ET; Mahendran R; Chiong E
Eur J Pharm Sci; 2015 May; 72():57-68. PubMed ID: 25772330
[TBL] [Abstract][Full Text] [Related]
13. Indigocarmine as a quantitative indicator of urothelial integrity.
Monson FC; Wein AJ; McKenna BA; Whitmore K; Levin RM
J Urol; 1991 Apr; 145(4):842-5. PubMed ID: 2005716
[TBL] [Abstract][Full Text] [Related]
14. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
Gao H; Zhang Q; Yang Y; Jiang X; He Q
Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
[TBL] [Abstract][Full Text] [Related]
15. A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application.
Silva C; Avelino A; Souto-Moura C; Cruz F
BJU Int; 2001 Sep; 88(4):355-60. PubMed ID: 11564021
[TBL] [Abstract][Full Text] [Related]
16. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J
Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619
[TBL] [Abstract][Full Text] [Related]
17. An ex vivo investigation into the transurothelial permeability and bladder wall distribution of the nonsteroidal anti-inflammatory ketorolac.
Williams NA; Bowen JL; Al-Jayyoussi G; Gumbleton M; Allender CJ; Li J; Harrah T; Raja A; Joshi HB
Mol Pharm; 2014 Mar; 11(3):673-82. PubMed ID: 24460452
[TBL] [Abstract][Full Text] [Related]
18. Poly - (l) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
Apfelthaler C; Anzengruber M; Gabor F; Wirth M
Eur J Pharm Biopharm; 2017 Jun; 115():131-139. PubMed ID: 28237713
[TBL] [Abstract][Full Text] [Related]
19. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
Mugabe C; Raven PA; Fazli L; Baker JH; Jackson JK; Liggins RT; So AI; Gleave ME; Minchinton AI; Brooks DE; Burt HM
Biomaterials; 2012 Jan; 33(2):692-703. PubMed ID: 22014457
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
